GMP/FDA requirements to aseptic production

被引：0

|

作者：

Langer, U

Mangel, A

机构：

[1] Concept Heidelberg, D-69007 Heidelberg, Germany

[2] Univ Mainz Klinikum, Mainz, Germany

来源：

PHARMAZEUTISCHE INDUSTRIE | 2002年 / 64卷 / 04期

关键词：

D O I：

暂无

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

引用

收藏

页码：375 / 383

页数：9

相关论文

共 50 条

[41] Meeting FDA process validation requirements
SIMS Deltec, St. Paul, United States
Medical Device and Diagnostic Industry, 1996, 18 (07):
[42] TECHNICAL REQUIREMENTS OF NEW FDA GUIDELINES
MYERS, GH
IEEE TRANSACTIONS ON ULTRASONICS FERROELECTRICS AND FREQUENCY CONTROL, 1986, 33 (01) : 101 - 101
[43] GMP REQUIREMENTS FOR PREMISES AND EQUIPMENT IN BLOOD ESTABLISHMENTS
Schaerer, C.
VOX SANGUINIS, 2013, 105 : 3 - 4
[44] Collaboration key to meeting excipient GMP requirements
Challener, Cynthia A.
Pharmaceutical Technology, 2017, 41 (02): : 36 - 39
[45] GMP requirements in Asia - Focus Japan, China
Bock, Michael
PHARMAZEUTISCHE INDUSTRIE, 2022, 84 (11): : 1279 - 1283
[46] GMP Aspects in Practice: System orientated GMP Inspections by the FDA/Experiences one year after introduction
Kirrstetter, R
PHARMAZEUTISCHE INDUSTRIE, 2003, 65 (08): : 796 - 798
[47] VITAMIN REQUIREMENTS OF ARTEMIA-SALINA IN ASEPTIC CULTURE
PROVASOLI, L
DAGOSTINA, A
AMERICAN ZOOLOGIST, 1962, 2 (03): : 439 - 439
[48] FDA发布饮食补充剂GMP提案
希雨
国外医药(植物药分册), 2004, (06) : 275 - 276
[49] Regulation: FDA revises postmarketing reporting requirements
Rios, Maribel
Pharmaceutical Technology, 2007, 31 (11)
[50] HISTORY OF FDA PATIENT PACKAGE INSERT REQUIREMENTS
不详
AMERICAN JOURNAL OF HOSPITAL PHARMACY, 1980, 37 (12): : 1660 - 1661

← 1 2 3 4 5 →